CTRL Therapeutics USA
Glencoe, US · Founded 2022 · Delaware corporation
Founders & leadership
DP
Derrell PorterNamed on SEC filing
SK
Shana KelleyNamed on SEC filing
MK
Michael KalosNamed on SEC filing
EV
Elena VibochNamed on SEC filing
Board
CT
Collin ToddBoard director
DO
David O'NeillBoard director
Reported raises · per SEC filings
Form D private placements$16.6M disclosed across 2 rounds · 2022–2024
▶$9.1MraisedSep 2024 · 5 investors · BiotechnologyRule 506(b)
▶$9.1MraisedSep 2024 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Derrell PorterExecutive Officer, Director
- Collin ToddDirector
- David O'NeillDirector
- Shana KelleyExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $9.1M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$7.5MraisedOct 2022 · 7 investors · BiotechnologyRule 506(b)
▶$7.5MraisedOct 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael KalosDirector
- Shana KelleyExecutive Officer, Director
- Elena VibochDirector
- David O'NeillDirector
- Offering amount
- $10.6M
- Amount sold
- $7.5M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has CTRL Therapeutics USA raised?
- CTRL Therapeutics USA has disclosed $16.6M raised across 2 rounds.
- Where is CTRL Therapeutics USA headquartered?
- CTRL Therapeutics USA is headquartered in Glencoe, US.